csirt@kutim:~/threat-intel/cve/CVE-2025-65947

Katalog CVE

CVSS 8.7 · High EPSS 0,35%

Kerentanan Uncontrolled Resource Consumption. Skor CVSS 4.0 8.7 (High) menurut github.com.

Deskripsi (NVD)

thread-amount is a tool that gets the amount of threads in the current process. Prior to version 0.2.2, there are resource leaks when querying thread counts on Windows and Apple platforms. In Windows platforms, the thread_amount function calls CreateToolhelp32Snapshot but fails to close the returned HANDLE using CloseHandle. Repeated calls to this function will cause the handle count of the process to grow indefinitely, eventually leading to system instability or process termination when the handle limit is reached. In Apple platforms, the thread_amount function calls task_threads (via Mach kernel APIs) which allocates memory for the thread list. The function fails to deallocate this memory using vm_deallocate. Repeated calls will result in a steady memory leak, eventually causing the process to be killed by the OOM (Out of Memory) killer. This issue has been patched in version 0.2.2.

Rincian

Terbit di NVD
21 November 2025
Terakhir diubah
17 Juni 2026
Status NVD
Deferred
CVSS 4.0
8.7 (High), sumber github.com
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X · uraikan di kalkulator
Jenis kelemahan (CWE)
CWE-400: Uncontrolled Resource Consumption
CWE-772: Missing Release of Resource after Effective Lifetime
EPSS (30 hari)
0,35% peluang dieksploitasi; lebih tinggi dari 26,3% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.